Related Experiment Video
Updated: Aug 5, 2026
08:38
Habituation and Prepulse Inhibition of Acoustic Startle in Rodents
Published on: September 1, 2011
Phenylpropanolamine-induced psychosis. Potential predisposing factors
1New York State Psychiatric Institute, Columbia University College of Physicians and Surgeons, NY 10032.
General Hospital Psychiatry
|September 1, 1994
Summary
Phenylpropanolamine (PPA) in decongestants can cause psychiatric side effects, even at recommended doses. Vulnerable individuals with a history of mood or psychotic disorders may be at higher risk.
Area of Science:
- Pharmacology
- Neuroscience
- Psychiatry
Background:
- Phenylpropanolamine (PPA) is a widely used sympathomimetic amine in over-the-counter and prescription medications.
- PPA is commonly found in nasal decongestants and appetite suppressants.
- Adverse effects of PPA are documented, but neuropsychiatric reactions are often underreported.
Observation:
- Neuropsychiatric reactions, including paranoid psychosis, have been reported with PPA use, even at recommended dosages.
- A case of paranoid psychosis following PPA-containing decongestant use is presented.
- Literature review reveals psychiatric adverse effects associated with PPA within recommended guidelines.
Findings:
- Potential risk factors for PPA-induced psychiatric adverse events include a history of mood spectrum disorder or psychosis, female sex, and family psychiatric history.
- The incidence of psychiatric adverse effects may be higher than reported, particularly in vulnerable populations.
- Symptoms in some cases resolved without antipsychotic medication.
Implications:
- Physicians should proactively inquire about patients' use of PPA-containing decongestants and diet aids.
- Further systematic investigation into PPA's adverse psychiatric effects in at-risk populations is warranted.
- Increased awareness of potential neuropsychiatric risks associated with PPA is crucial for patient safety.
Related Concept Videos
01:28Psychosis and Antipsychotic Drugs: Overview
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:24Mania and Antimanic Drugs: Overview
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
01:27Panic Disorder
Panic disorder is an anxiety disorder characterized by recurrent and sudden minutes-long episodes of intense fear, known as panic attacks. These attacks may feel like heart attacks and often happen without warning or a specific cause. They can include symptoms such as rapid heart rate, shortness of breath, chest pain, trembling, sweating, dizziness, and a sense of helplessness. During a panic attack, individuals may feel as though they are experiencing a heart attack or are in a...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...